| Literature DB >> 25649330 |
Yoshihisa Hirakawa1, Kazumasa Uemura1.
Abstract
OBJECTIVE: Japan introduced a new metabolic syndrome (MetS) screening and intervention program. However, the specific benefits of the program have not yet been identified. The aim of our study was to highlight the role of the program in reducing risks related to MetS in a Japanese rural area.Entities:
Keywords: Tokutei Kenshin; health checkup; health education; metabolic syndrome; rural area
Year: 2013 PMID: 25649330 PMCID: PMC4309339 DOI: 10.2185/jrm.2866
Source DB: PubMed Journal: J Rural Med ISSN: 1880-487X
Figure 1Flow diagram of participant recruiting and follow up.
Figure 2Metabolic syndrome diagnostic criteria in Japan.
Baseline characteristics of subjects
| Male (n=179) | Female (n=234) | ||
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Age, year | 61.5 ± 7.8 | 60.4 ± 8.1 | |
| Uric acid, mg/dl | 5.7 ± 1.3 | 4.4 ± 0.9 | |
| FBG, mg/dl | 97.8 ± 10.8 | 94.3 ± 11.9 | |
| HbA1C, % | 5.4 ± 0.4 | 5.4 ± 0.4 | |
| T-C, mg/dl | 195.2 ± 31.7 | 209.4 ± 28.6 | |
| HDL-C, mg/dl | 58 ± 14.1 | 66.3 ± 14.3 | |
| TG, mg/dl | 116.4 ± 77.0 | 82.1 ± 34.9 | |
| LDL-C, mg/dl | 116.7 ± 30.3 | 126.6 ± 26.8 | |
| SBP, mmHg | 124.4 ± 14.0 | 117.1 ± 14.8 | |
| DBP, mmHg | 75.9 ± 7.8 | 71.3 ± 7.6 | |
| Hight, cm | 165.4 ± 6.3 | 153.0 ± 5.4 | |
| BW, kg | 62.4 ± 8.5 | 52.0 ± 8.2 | |
| BMI | 22.7 ± 2.6 | 22.1 ± 3.1 | |
| Abdominal circumference, cm | 81.0 ± 6.8 | 77.8 ± 8.5 |
FBG, fasting blood glucose; HbA1c, hemoglobin A1c; T-C, total cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides: LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; BW, body weight.
Support group subjects’ metabolic risk factors at baseline and after 12 months (n=88)
| Baseline | At 12 months | |||||
|---|---|---|---|---|---|---|
| n | (%) | n | (%) | |||
| Diabetes riska | 69 | (78.4) | 69 | (78.4) | 1.000 | |
| Dyslipidemia riskb | 16 | (18.2) | 16 | (18.2) | 1.000 | |
| Hypertension riskc | 33 | (37.5) | 32 | (36.4) | 1.000 | |
| Accumulation of visceral fatd | 58 | (65.9) | 59 | (67.0) | 1.000 | |
P value was determined by McNemar test. a Subjects at diabetes risk were defined as those with one of the following: FBG ≥ 110 mg/dl or HbA1C ≥ 5.2%. b Subjects at dyslipidemia risk were defined as those with one of the following: TG ≥ 150 mg/dl or HDL-C < 40 mg/dl. c Subjects at hypertension risk were defined as those with one of the following: SBP ≥ 130 mmHg or DBP ≥ 85 mmHg. d Subjects with accumulation of visceral fat were defined as those with one of the following: abdominal circumference ≥ 85 cm for males or 90 cm for females or abdominal circumference < 85 cm for males or 90 cm for females and BMI ≥ 25.
Non-support group subjects’ metabolic risk factors at baseline and after 12 months (n=325)
| Baseline | At 12 months | |||||
|---|---|---|---|---|---|---|
| n | (%) | n | (%) | |||
| Diabetes riska | 249 | (76.6) | 244 | (75.1) | 0.560 | |
| Dyslipidemia riskb | 38 | (11.7) | 34 | (10.5) | 0.596 | |
| Hypertension riskc | 83 | (25.5) | 96 | (29.5) | 0.112 | |
| Accumulation of visceral fatd | 0 | (0) | 16 | (4.9) | 0.000 | |
P value was determined by McNemar test. a Subjects at diabetes risk were defined as those with one of the following: FBG ≥ 110 mg/dl or HbA1C ≥ 5.2%. b Subjects at dyslipidemia risk were defined as those with one of the following: TG ≥ 150 mg/dl or HDL-C < 40 mg/dl. c Subjects at hypertension risk were defined as those with one of the following: SBP ≥ 130 mmHg or DBP ≥ 85 mmHg. d Subjects at accumulation of visceral fat were defined as those with one of the following: abdominal circumference ≥ 85 cm for males or 90 cm for females or abdominal circumference < 85 cm for males or 90 cm for females and BMI ≥ 25.